CCL20 is also involved in controlling the immune response, and has been found to be overexpressed in inflammatory bowel disease (IBD), psoriasis and rheumatoid arthritis, leading to the occurrence of autoimmune diseases (AIDs) [43–46]. This evidence concerns the gene CCL20 and rheumatoid arthritis.